Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J K Zubieta

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Molecular Psychiatry|December 17, 2014
Molecular mechanisms of placebo responses in humansM Peciña, J-K Zubieta
Molecular Psychiatry|March 24, 2015
Over a decade of neuroimaging studies of placebo analgesia in humans: what is next?M Peciña, J-K Zubieta
Biological Psychiatry|June 1, 1992
Depression after cyproheptadine: MAO treatmentJ K Zubieta, M A Demitrack
Fertility and Sterility|October 10, 2001
Neuroimaging of aging and estrogen effects on central nervous system physiologyY R Smith, J K Zubieta
Journal of Child and Adolescent Psychopharmacology|July 28, 2009
Is there a role of serotonin in the disruptive behavior disorders? A literature reviewJ K Zubieta, N E Alessi
Journal of Clinical Psychopharmacology|October 1, 1992
Acute and chronic administration of trazodone in the treatment of disruptive behavior disorders in childrenJ K Zubieta, N E Alessi
Journal of Clinical Psychopharmacology|October 1, 1991
Possible bupropion precipitation of mania and a mixed affective stateJ K Zubieta, M A Demitrack
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1993
Autoradiographic mapping of M3 muscarinic receptors in the rat brainJ K Zubieta, K A Frey
British Journal of Pharmacology|December 1, 1986
Activation and desensitization of presynaptic alpha 2-adrenoceptors after inhibition of neuronal uptake by antidepressant drugs in the rat vas deferensJ A García-Sevilla, J K Zubieta
Molecular Psychiatry|March 21, 2012
Role of μ-opioid system in the formation of memory of placebo responsesM Peciña, C S Stohler, J-K Zubieta
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Molecular Psychiatry|December 17, 2014
Molecular mechanisms of placebo responses in humansM Peciña, J-K Zubieta
Molecular Psychiatry|March 24, 2015
Over a decade of neuroimaging studies of placebo analgesia in humans: what is next?M Peciña, J-K Zubieta
Biological Psychiatry|June 1, 1992
Depression after cyproheptadine: MAO treatmentJ K Zubieta, M A Demitrack
Fertility and Sterility|October 10, 2001
Neuroimaging of aging and estrogen effects on central nervous system physiologyY R Smith, J K Zubieta
Journal of Child and Adolescent Psychopharmacology|July 28, 2009
Is there a role of serotonin in the disruptive behavior disorders? A literature reviewJ K Zubieta, N E Alessi
Journal of Clinical Psychopharmacology|October 1, 1992
Acute and chronic administration of trazodone in the treatment of disruptive behavior disorders in childrenJ K Zubieta, N E Alessi
Journal of Clinical Psychopharmacology|October 1, 1991
Possible bupropion precipitation of mania and a mixed affective stateJ K Zubieta, M A Demitrack
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1993
Autoradiographic mapping of M3 muscarinic receptors in the rat brainJ K Zubieta, K A Frey
British Journal of Pharmacology|December 1, 1986
Activation and desensitization of presynaptic alpha 2-adrenoceptors after inhibition of neuronal uptake by antidepressant drugs in the rat vas deferensJ A García-Sevilla, J K Zubieta
Molecular Psychiatry|March 21, 2012
Role of μ-opioid system in the formation of memory of placebo responsesM Peciña, C S Stohler, J-K Zubieta
Pageof 5